ARTICLE | Clinical News
Factor X coagulation product: Phase III data
April 27, 2015 7:00 AM UTC
Bio Products Laboratory said the criteria for treatment success were met in an open-label Phase III trial in 16 patients with severe or moderate hereditary Factor X deficiency evaluating the company’s...